Lisa Anderson, PhD, Senior Director of Research for the National Alopecia Areata Foundation (NAAF), joins That's Derm Good! to discuss her transition into the world of alopecia areata, an autoimmune disease characterized by unpredictable hair loss. 

DISCLAIMER: This podcast is for informational purposes only and should not be considered medical or health advice. This podcast does not substitute medical treatment. Always consult a doctor or dermatologist regarding medical advice, diagnoses, or treatment.

Alopecia areata is an autoimmune disease that affects approximately 2% of the population, equating to about 7 million people in the United States and 160 million worldwide. This condition is characterized by unpredictable hair loss, which can manifest in various forms, ranging from small patches to complete hair loss on the scalp and body, known as alopecia totalis or universalis. 

ADVERTISING: This episode is sponsored by Dermavant. 

Dr. Anderson’s journey illustrates the intersection of personal experience, professional expertise, and advocacy in alopecia areata. With a background in neurosciences, Lisa transitioned into patient advocacy, ultimately finding her role at NAAF during a pivotal time in the organization’s history. 

Through initiatives like the annual patient conference and the Walk for Alopecia, NAAF fosters a sense of community among those affected, helping to combat the feelings of isolation that often accompany the disease, which is so beneficial. As Dr. Anderson notes, the only predictable aspect of alopecia areata is its unpredictability. The best way to handle such unpredictability is by connecting to a community; NAAF helps foster communication and fight the isolation attached to alopecia areata.

NAAF provides resources, community support, and educational initiatives to raise awareness about alopecia areata. For more information about the National Alopecia Areata Foundation, visit www.naaf.org.

This episode is produced by Skip The Boring Stuff, a podcast strategy company for business owners.